Price war for Novartis cardiac drug begins as JB Pharma implements 50% cut ...Middle East

Novartis' blockbuster drug is set to lose patent in Jan; JB Pharma, one of the four marketers in India of generi versions, has slashed the price of its brand Azmarda to Rs 39.6 a tablet

Hence then, the article about price war for novartis cardiac drug begins as jb pharma implements 50 cut was published today ( Monday 05/12/2022 - 12:24 PM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Price war for Novartis cardiac drug begins as JB Pharma implements 50% cut )

Also on site :

• ROE Visual célèbre 20 ans de technologie LED pionnière
• Judd Advisory Supports Successful FCA Authorisation of European Mid-Cap Investment Manager, Haverstock Capital
• Conscientia Health Honored as "Best Psychiatrist" by Patient Ratings on Google Reviews